PalGlyN-palmitoylglycine
An endogenous lipoamino acid of skin and spinal cord, the most potent activator of the GPR132 receptor.
C₁₈H₃₅NO₃
CAS 2441-41-0
- Family
- Endocannabinoid or related mediatorEndocannabinoidome
- Molar mass
- 313.50 g/mol
Updated on
In plain terms
N-palmitoylglycine is a lipid the body makes itself, by attaching a fatty acid to an amino acid. It is found mainly in skin and spinal cord, where it acts on the activity of sensory neurons.
Receptors and activity
Target network
- Activates
- Blocks or inhibits
The lower the cited value, the closer the target sits to PalGly: one ring per factor of 100. A target with no measured value stays on the edge.
Cited values
- GPR132 (G2A)Agonistno measured value cited
Most potent activator among the N-acylamides tested: N-palmitoylglycine > 9-HODE ≈ N-linoleoylglycine > linoleamide > N-oleoylglycine ≈ N-stearoylglycine > N-arachidonoylglycine > N-docosahexaenoylglycine, with activity comparable to that of 9-HODE; physiological tissue concentrations are enough to activate the receptor, and arginine 203 of the fifth transmembrane domain is critical (Foster 2019). No EC50 is given in the abstract
- Dorsal horn nociceptive neurons (heat-evoked firing)Inhibitorno measured value cited
Potent inhibition of heat-evoked firing in the rat; transient calcium influx in dorsal root ganglion neurons and in the F-11 line, sensitive to pertussis toxin, dependent on extracellular calcium, blocked by ruthenium red, SK&F96365 and lanthanum, followed by NO production suppressed by 7-nitroindazole (Rimmerman 2008). No potency value published in the abstract
Pharmacology
N-palmitoylglycine is an endogenous lipoamino acid, the saturated congener of N-arachidonoylglycine in the N-acylglycine family. Rimmerman and colleagues identified it in 2008 in rat lipid extracts after postulating its existence from the availability of its two building blocks, palmitic acid and glycine, and found it at high levels in skin and spinal cord, raised in FAAH-deficient mice. In the same work it inhibited heat-evoked firing of nociceptive dorsal horn neurons and triggered a transient calcium influx in sensory neurons, sensitive to pertussis toxin and followed by nitric oxide production, which places it in sensory signalling rather than in cannabinoid neurotransmission. Its best-characterised molecular target is the lipid receptor GPR132 (G2A): it is the most potent activator among the N-acylamides tested, ahead of 9-HODE and N-linoleoylglycine, at concentrations tissues actually reach (Foster 2019). It does not directly activate the CB1 and CB2 receptors. Its interest therefore lies in the lipid entourage of the endocannabinoid system: for this class, inhibition of T-type calcium channels has been proposed as the mechanism of the analgesia observed, N-arachidonoylglycine and NAGABA-OH producing a thermal analgesia abolished in mice lacking Cav3.2, though N-palmitoylglycine itself was not tested in that work (Barbara 2009).
Key sources.
- Rimmerman et al. 2008, Mol Pharmacol: N-palmitoylglycine, an endogenous lipid modulating calcium influx and NO production in sensory neurons (new tab)PMID 18424551
- Foster et al. 2019, Pharmacol Res Perspect: N-palmitoylglycine and other N-acylamides activate the lipid receptor G2A/GPR132 (new tab)PMID 31768260
- Barbara et al. 2009, J Neurosci: inhibition of T-type calcium channels underlies the analgesic effects of endogenous lipoamino acids (new tab)PMID 19846698
- PubChem CID 151008, N-palmitoylglycine (new tab)
History
- Source
- An endogenous mammalian lipid, formed after cellular stimulation and present at high levels in rat skin and spinal cord (Rimmerman 2008). It belongs to the lipoamino acid family, the saturated congener of N-arachidonoylglycine, and comes from no plant source.
Biosynthetic pathway
In vivo
Conjugation of palmitic acid, a saturated sixteen-carbon fatty acid, with glycine. For the family's lead compound, N-arachidonoylglycine, two routes are described: direct conjugation of the fatty acid to glycine and oxidative metabolism of anandamide; it was the existence of enzymes conjugating fatty acids with glycine that prompted the hypothesis of endogenous N-palmitoylglycine formation (Rimmerman 2008). Its elevation in FAAH-deficient mice indicates that its tissue level is under enzymatic control. This route is distinct from that of N-acylethanolamines such as anandamide, where ethanolamine rather than an amino acid carries the amide function.
Legal framework
- European Union
No control at Union level and no listing in the schedules of the 1961 and 1971 United Nations conventions: it is a normal lipid constituent of animal tissues, used as a research reagent.
- France
An endogenous mammalian molecule with no narcotic status: it is listed neither as a narcotic nor as a psychotropic substance (orders of 22 February 1990), and it does not belong to the benzo[c]chromene family covered by the ANSM decisions of June 2024. It is naturally present in the body and subject to no restriction.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Endocannabinoid or related mediator › Endocannabinoidome
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
No dedicated article.
References
- Rimmerman et al. 2008, Mol Pharmacol: N-palmitoylglycine, an endogenous lipid modulating calcium influx and NO production in sensory neurons (new tab)PMID 18424551
- Foster et al. 2019, Pharmacol Res Perspect: N-palmitoylglycine and other N-acylamides activate the lipid receptor G2A/GPR132 (new tab)PMID 31768260
- Barbara et al. 2009, J Neurosci: inhibition of T-type calcium channels underlies the analgesic effects of endogenous lipoamino acids (new tab)PMID 19846698
- PubChem CID 151008, N-palmitoylglycine (new tab)
Identifiers
Names
- Common name
- N-palmitoylglycine
- IUPAC name
- 2-(hexadecanoylamino)acetic acid
- Other names
- PalGly · N-palmitoyl glycine · palmitoylglycine
Identifiers
- Formula
- C₁₈H₃₅NO₃
- CAS
- 2441-41-0
- PubChem CID
- 151008(new tab)
- InChIKey
- KVTFEOAKFFQCCX-UHFFFAOYSA-N
- SMILES
- CCCCCCCCCCCCCCCC(=
O) NCC(= O) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.